Member Info for Howzaty

Job done then. Clearly preCISION works. So a short wait until the share price takes to the vertical!

Job done then. Clearly preCISION works. So a short wait until the share price takes to the vertical!

100% 255M, 10% 25.5M, 1% 2.5M, 0.5% 1.25M ....

Today my prioities are do we have bacon, are there enough eggs and when did I buy those baps? And is there space in the fridge for the wine and beer. Blue sky day all the way. Tomorrow, ... let there be DE.

"Anybody who ..." you are entitled to your opinion but since you are clearly an idiot please keep such thoughts to yourself. TA is a tool which offers certain insights, it is a lot better than casting runes, on the whole!

Poster presentation Title: AVA6000, a novel Precision medicine, targeted to the tumor microenvironment via Fibroblast Activation Protein (FAP) mediated cleavage Monday Apr 11, 2022 1:30 PM - 5:00 PM CT (18:30 - 22:00 GMT).

I mean thats got to be worth something, right.

I dont know about you all but it makes me feel good to know that even if AVA6000 dosent work in humans at least we will be able to spare the worlds rodents from this awful disease.

Andecc having bought at 271p it must be quite comforting to know that 2500p is a conservative valuation if AVA6000 comes good. Rest assured I and many others feel your pain, quite a way to go for me but curiously the potential here is such that I feel quite relaxed about my 'misplaced cash', a lesson or two learned though thats for sure. Good luck.

PL I beg to differ, best test in the world binding to N and P at a time when the focus will rightly be on Sensitivity to provide a Green Light for attendance at meetings and the like going forward and dare I say it flights and such as well. As we all know Covid has not gone away and folk will tire of catching it over and over again not to mention the risk of a seriously nasty varient. I think time will prove Avacta are right to complete this second generation LFT. The truth about the rubbish tests is out there dont think that will happen again, although has anyone seen Sensitivity numbers of the Vatic Test at ct anything?

Once established as the best in world Covid LFT it becomes a no effort income stream for Avacta so whats not to like, expect perhaps ongoing testing to confirm sensitivity with variants. Anyhoo other AffiDX tests are hopefully not that far off.

A hard night ... flagship LFT ...

As I said months ago AS did not strike me as someone likely to give up and admit defeat on his flagship IVD product. There will be more difficulties I expect with driving down costs and improving its Green Credentials than other aspects. But we will see Shortly.

I particularly liked the Partnership page , the discussion around Tufts and PD-L1 and the video which though some years old I had not seen before. Clearly all looking good.

Expensive and immediately redundant when AVA6000 is proven. Am looking forward to tomorrorow with some concerns given AS propensity for crashing the share price deliberately or otherwise, on the last occasion he must have surely been aware of consequences of what he said so I count ghat as deliberate. Anyhoo, fingers crossed and GLA, dont forget early to bed cos you will be up early tomorrow.

Tony, its all too easy to forget in discussing Avacta how much folk with Cancer stand to benefit and its that that is really the important thing. Wishing you the very best of luck.

Regarding dosage, from what I have read and understood large dosage may not necessarily deliver the best outcome for patients, rather more cycles may be the dosing regime selected as giving best results. Both approaches equally valid and only possible because of reduced toxicity. This will I gather be the focus of attention under phase 1b.

In my opinion no one could have anticipated the shenanigans that the present Government and its acolytes got up to in relation to Covid testing. The was a real effort to ensure PCR testing delivered billions to a select few, look at the delays and downright obstruction BAMS was subject to and I could go on but am frankly bored by it. We are where we are and hopefully AS can realise significant profit from the Diagnostics Division as a whole, or otherwise sell it off, and make a success of AVA6000 and the preCISION pipeline. All will be revealed in a little while. Millionaires made of those with holdings of 100k and more. Time will tell GLA LTH we must truely have the patience of Saints to get this far and still be holding but hey ho, nothing ventured nothing gained.

GMCC, I agree there is a lot to play for in the diagnostics space. Lets hope we hear that there are new products nearing approval, less than two would strike me as dilatory given the resources available, we shall soon see.

Regarding the Avacta LFT we have no idea what the full scope of work on the LFT is, it may be its beyond antibody replacement. I hope this is indeed the case and we see an improved product with greener credentials. Again, since we have been told b all we are left guessing. But hey ho all to be revealed Shortly.